| Gerald L Alatelo, PSYD | |
|
4105 Tudor Centre Dr, Anchorage, AK 99508-5902 | |
| (907) 565-4000 | |
| (907) 565-4011 |
| Full Name | Gerald L Alatelo |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 4105 Tudor Centre Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770528234 | NPI | - | NPPES |
| MH6578 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 438 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gerald L Alatelo, PSYD 4105 Tudor Centre Dr, Anchorage, AK 99508-5902 Ph: (907) 565-4000 | Gerald L Alatelo, PSYD 4105 Tudor Centre Dr, Anchorage, AK 99508-5902 Ph: (907) 565-4000 |
News Archive
Resilience—understood as the set of personal resources that help individuals deal effectively with adversity, protecting them from the negative health effects of stress—is receiving increasing attention from researchers.
AMT today announced that its adeno-associated viral vector (AAV) expressing lipoprotein lipase (LPL) product has been designated as an orphan medicinal product for the treatment of LPL deficiency by the European Commission. This decision follows a positive recommendation by the European Agency for the Evaluation of Medicinal Products.
Human Genome Sciences, Inc. announced today a license agreement with DakoCytomation A/S (Glostrup, Denmark), under which DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology based on the TRAIL Receptor-1 (TRAIL-R1) and TRAIL Receptor-2 (TRAIL-R2) proteins.
At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.
The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.
› Verified 8 days ago
James Kyle Timmons, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Potlatch Cir, Anchorage, AK 99503 Phone: 907-947-1862 | |
Raymond Pastorino, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-562-1603 | |
Dr. Sally Schliesmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Redwood Pl, Anchorage, AK 99508 Phone: 907-278-1200 Fax: 907-276-3147 | |
Cale Palmer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3001 C St, Anchorage, AK 99503 Phone: 907-273-4023 | |
Suzette Lewis, PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1825 Academy Dr, Anchorage, AK 99507 Phone: 907-522-7080 Fax: 907-522-7088 | |
Dennis Gall, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4050 Lake Otis Pkwy Ste 105, Anchorage, AK 99508 Phone: 907-433-9628 | |
Kelley Russell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-257-4700 |